Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

University of Maryland/Greenebaum Cancer Center, Baltimore

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne

University of Michigan Comprehensive Cancer Center, Ann Arbor

Wayne State University/Karmanos Cancer Institute, Detroit

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

Metro Minnesota Community Oncology Research Consortium, Saint Louis Park

Mayo Clinic, Rochester

NorthShore University HealthSystem-Evanston Hospital, Evanston

Ingalls Memorial Hospital, Harvey

Northwestern University, Chicago

University of Chicago Comprehensive Cancer Center, Chicago

Illinois CancerCare-Peoria, Peoria

Decatur Memorial Hospital, Decatur

Southern Illinois University School of Medicine, Springfield

Washington University School of Medicine, St Louis

Mercy Hospital Saint Louis, St Louis

Mayo Clinic in Arizona, Scottsdale

USC / Norris Comprehensive Cancer Center, Los Angeles

City of Hope Comprehensive Cancer Center, Duarte

City of Hope South Pasadena, South Pasadena

University of California Davis Comprehensive Cancer Center, Sacramento

Penn State Milton S Hershey Medical Center, Hershey